This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Taro Pharmaceutical Industries Beheer
Beheer criteriumcontroles 2/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Uday Baldota
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 6.8yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 8.8yrs |
Gemiddelde ambtstermijn bestuur | 7.5yrs |
Recente managementupdates
Recent updates
Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity
Dec 12Taro Pharmaceutical: Sun Pharma Deal Uncertain, No Discernible Value Beyond NAV (Rating Downgrade)
Aug 16Taro Pharmaceutical: Potential Value In Sun Pharma Offer
Jun 02Taro Pharmaceutical: Stagnating Growth At 1.6% Trailing Earnings Yield, Rate Hold
Feb 24Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68, revenue of $139.2M misses by $23.92M
Jan 24Taro Pharmaceutical Non-GAAP EPS of $0.66 misses by $0.18, revenue of $130.5M misses by $30.52M
Oct 28Taro Pharmaceutical hits 52-week low; down 28% YTD
Aug 15Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M
Jul 27Taro Pharmaceutical: 10%+ Projected Earnings Yield Is A Strong Calling Card
Jul 14We Think Taro Pharmaceutical Industries' (NYSE:TARO) Healthy Earnings Might Be Conservative
Aug 03A Look At Taro Pharmaceutical Industries' (NYSE:TARO) Share Price Returns
Jan 26CEO
Uday Baldota (54 yo)
6.8yrs
Tenure
Mr. Uday V. Baldota has been Director at Association for Accessible Medicines. He has been the Chief Executive Officer of Taro Pharmaceutical Industries Ltd. since August 28, 2017 and served as its Co-Chie...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | 6.8yrs | geen gegevens | geen gegevens | |
VP, CFO & Chief Accounting Officer | 2.5yrs | geen gegevens | geen gegevens | |
VP & Head of Operations | 9.5yrs | geen gegevens | geen gegevens | |
VP and Head of R&D | 12.7yrs | geen gegevens | geen gegevens | |
Vice President of Technical Services | 14.4yrs | geen gegevens | geen gegevens | |
Vice President of Scientific and Technical Compliance Manager | no data | geen gegevens | geen gegevens | |
VP, General Counsel & Secretary | 4.2yrs | geen gegevens | geen gegevens | |
Vice President of Sales & Marketing | 11.3yrs | US$616.14k | geen gegevens | |
VP & Head of Human Resource | no data | geen gegevens | geen gegevens | |
Head of Procurement | 12.5yrs | geen gegevens | geen gegevens | |
VP & Head of Information Technology | 8yrs | geen gegevens | geen gegevens | |
VP & Head of U.S. Generics Rx | 5.2yrs | geen gegevens | geen gegevens |
8.8yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren management: TARO's management team is seasoned and experienced (8.8 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | 7.5yrs | geen gegevens | geen gegevens | |
Chairman of the Board | 10.9yrs | US$1.00m | geen gegevens | |
Independent Director | 4.3yrs | geen gegevens | geen gegevens | |
Director | 13.8yrs | US$500.00k | geen gegevens | |
Director | 13.1yrs | geen gegevens | geen gegevens | |
Independent Director | 7.5yrs | geen gegevens | geen gegevens | |
Vice Chairman | 7.5yrs | geen gegevens | geen gegevens | |
Independent Director | less than a year | geen gegevens | geen gegevens |
7.5yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: TARO's board of directors are considered experienced (7.5 years average tenure).